US President Trump unveils launch of TrumpRx.gov website and said prescription drugs will be available tonight on the website

The launch of TrumpRx.gov, facilitating access to prescription drugs, may impact healthcare stocks and the broader equities market.

Newsquawk StaffPublished On the live feed at 5 more headlines followed before this page went public
Newsquawk headlinesUTC

Pfizer (PFE) launches cost savings program on TrumpRx, lowering drug costs for millions of Americans

South Korea temporarily halts program trading on the KOSPI amid volatility, with KOSPI down around 4%

US President Trump unveils launch of TrumpRx.gov website and said prescription drugs will be available tonight on the website

[MARKET UPDATE] Asia-Pac stocks begin lower as the global market rout persists following the continued tech woes and weak US labour market data

Australia sells AUD 800mln 1.00% December 2030 bonds, b/c 4.14, avg. yield 4.3641%

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Says:

  • 16 of the 17 largest pharmaceutical companies have signed agreements.
Context

With major pharmaceutical companies onboard, this announcement indicates a strategic push in healthcare policy that could resonate across sectors, particularly in pharmaceuticals and healthcare providers. Keep an eye on related equities and commodities, like gold and crude, in response to this development.

Related headlines

The whole workspace, free to try.

Try it free